Intercept Pharmaceuticalsincis A Biopharmaceutical Company Based In Morristownnew Jerseyfounded In 2002The Company Focuses On Researchingdevelopingand Commercializing Treatments For Non Viralprogressive Liver Diseasesits Lead Productocalivaobeticholic Acid Is A Bile Acid Analog Used Primarily For Treating Primary Biliary Cholangitispbcin Adultsintercept Is Also Exploring Ocaliva For Other Conditionsincluding Nonalcoholic Steatohepatitisnash And Is Developing Additional Candidates Like Int 787 For Severe Alcohol Associated Hepatitis As Of 2023Intercept Pharmaceuticals Operates As A Subsidiary Of Alfasigma Spathe Company Employs Approximately 341 People And Markets Its Products Through An Internal Commercial Organization And Third Party Distributors In The United Stateseuropeand Canadawith A Commitment To Addressing Rare And Serious Liver Diseasesintercept Pharmaceuticals Plays A Significant Role In The Biopharmaceutical Industry
No conferences found for this company.
| Company Name | Intercept Pharmaceuticals Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
